Skip to main content
Fig. 4 | World Journal of Surgical Oncology

Fig. 4

From: Role of PARP inhibitors beyond BRCA mutation and platinum sensitivity in epithelial ovarian cancer: a meta-analysis of hazard ratios from randomized clinical trials

Fig. 4

Forest plot showing progression-free survival in various subgroup analysis in PARP inhibitor arm (case) and chemotherapy/placebo arm(control); A HRD, BRCA unknown population; B BRCAmutated, HRD population; C HRD, BRCA wildtype population; D Homologous recombination proficient population; E BRCA wildtype, HRD unknown population; F BRCAmutated, HRD unknown population

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us